Eczema cream ‘steroid-sparing’

According to a team of international researchers, up to one-third of patients with eczema are not compliant with existing topical corticosteroids (TCS) treatments because of corticophobia — a fear of the potential side effects. 

But the non-steroid alternative pimecrolimus (Elidel, Novartis) is safe and effective first-line for atopic dermatitis (AD) in infants and young children, researchers said. 

More than 2400 children aged 3—24 months were in the five-year, open-label study funded by Novartis — the